| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Common Stock | +Options Exercise | $475,250 | +5,000 | +23.83% | $95.05 | 25,978 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Disposed to Issuer | -$475,286 | -3,281 | -12.63% | $144.86 | 22,697 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Tax liability | -$98,070 | -677 | -2.98% | $144.86 | 22,020 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | +Options Exercise | $79,335 | +2,119 | +9.62% | $37.44 | 24,139 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Disposed to Issuer | -$79,383 | -548 | -2.27% | $144.86 | 23,591 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Tax liability | -$89,523 | -618 | -2.62% | $144.86 | 22,973 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Sell | -$3,047 | -21 | -0.09% | $145.08 | 22,952 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Sell | -$10,736 | -74 | -0.32% | $145.09 | 22,878 | Nov 7, 2022 | Direct | |
| transaction | EOG | Common Stock | -Sell | -$275,663 | -1,900 | -8.3% | $145.09 | 20,978 | Nov 7, 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Stock Appreciation Rights | -Options Exercise | $0 | -5,000 | -100% | $0.00 | 0 | Nov 7, 2022 | Common Stock | 5,000 | $95.05 | Direct | F1 |
| transaction | EOG | Stock Appreciation Rights | -Options Exercise | $0 | -2,119 | -49.93% | $0.00 | 2,125 | Nov 7, 2022 | Common Stock | 2,119 | $37.44 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The SARs granted became exercisable in 25% increments beginning one year from the September 29, 2016 date of grant and on each of the next three grant date anniversaries. The SARs granted became fully exercisable on September 29, 2020. |
| F2 | The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted will become fully exercisable on September 28, 2023. |